For systemic inflammation, serum levels of C-reactive protein (CRP) and neutrophil-to-lymphocyte ratio (NLR) derived from complete blood count have been well investigated as prognostic inflammatory markers in cancer patients [8, 9]. Here, CRP is linked to cancer.